Corbus Pharmaceuticals Holdings, Inc.Corbus Pharmaceuticals Holdings, Inc.Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc.

No trades
See on Supercharts

Price target

63.000.000.00%
The 8 analysts offering 1 year price forecasts for CRBP have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to CRBP in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CRBP EPS for the last quarter is −0.90 USD despite the estimation of −1.19 USD. In the next quarter EPS is expected to reach −0.95 USD. Track more of Corbus Pharmaceuticals Holdings, Inc. financials and stay on top of what is up with the company.
In the next quarter Corbus Pharmaceuticals Holdings, Inc. revenue is expected to reach 0.00 USD. Check out Corbus Pharmaceuticals Holdings, Inc. revenue and earnings and make informed decisions.
According to analysts, CRBP price target is 63.00 USD with a max estimate of 82.00 USD and a min estimate of 40.00 USD. Check if this forecast comes true in a year, meanwhile watch Corbus Pharmaceuticals Holdings, Inc. stock price chart and keep track of the current situation with CRBP news and stock market news.
We've gathered opinions of 8 analysts rating CRBP stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.